Abstract:Alternative splicing (AS), in higher eukaryotes, is one of the mechanisms of post-transcriptional regulation that generate multiple transcripts from the same gene. One particular mode of AS is the skipping event where an exon may be alternatively excluded or constitutively included in the resulting mature mRNA. Both transcript isoforms from this skipping event site, i.e. in which the exon is either included (inclusion isoform) or excluded (skipping isoform), are typically present in one cell, and maintain a subtle balance that is vital to cellular function and dynamics. However, how the prevailing conditions dictate which isoform is expressed and what biological factors might influence the regulation of this process remain areas requiring further exploration. In this study, we have developed a novel computational method, graph-based exon-skipping scanner (GESS), for de novo detection of skipping event sites from raw RNA-seq reads without prior knowledge of gene annotations, as well as for determining the dominant isoform generated from such sites. We have applied our method to publicly available RNA-seq data in GM12878 and K562 cells from the ENCODE consortium and experimentally validated several skipping site predictions by RT-PCR. Furthermore, we integrated other sequencing-based genomic data to investigate the impact of splicing activities, transcription factors (TFs) and epigenetic histone modifications on splicing outcomes. Our computational analysis found that splice sites within the skipping-isoform-dominated group (SIDG) tended to exhibit weaker MaxEntScan-calculated splice site strength around middle, ‘skipping’, exons compared to those in the inclusion-isoform-dominated group (IIDG). We further showed the positional preference pattern of splicing factors, characterized by enrichment in the intronic splice sites immediately bordering middle exons. Finally, our analysis suggested that different epigenetic factors may introduce a variable obstacle in the process of exon–intron boundary establishment leading to skipping events.

Computational Identification of Tissue-Specific Splicing Regulatory Elements in Human Genes from RNA-Seq Data

Genome-wide Prediction of Cis-Acting RNA Elements Regulating Tissue-Specific Pre-Mrna Alternative Splicing

Model-Based Prediction Of Cis-Acting Rna Elements Regulating Tissue-Specifc Alternative Splicing

Computational Identification of Specific Splicing Regulatory Elements from RNA-seq in Lung Cancer.

Detecting Tissue-Specific Regulation of Alternative Splicing As a Qualitative Change in Microarray Data.

RNA-Seq Analysis of Differential Splice Junction Usage and Intron Retentions by DEXSeq

Computational Analysis Reveals a Correlation of Exon-Skipping Events with Splicing, Transcription and Epigenetic Factors.

Integrating many co-splicing networks to reconstruct splicing regulatory modules

Integrated Analysis of a Compendium of RNA-Seq Datasets for Splicing Factors.

Genome-wide Identification and Predictive Modeling of Tissue-Specific Alternative Polyadenylation.

Identification and comparison of motifs in brain-specific and muscle-specific alternative splicing

Tissue Usage Preference and Intrinsically Disordered Region Remodeling of Alternative Splicing Derived Proteoforms in the Heart

Defining The Regulatory Network Of The Tissue-Specific Splicing Factors Fox-1 And Fox-2

The Identification Of Switch-Like Alternative Splicing Exons Among Multiple Samples With Rna-Seq Data

Systematic Reconstruction of Splicing Regulatory Modules by Integrating Many RNA-seq Datasets

TransTEx: novel tissue-specificity scoring method for grouping human transcriptome into different expression groups

Mapping RNA splicing variations in clinically accessible and nonaccessible tissues to facilitate Mendelian disease diagnosis using RNA-seq

SpliceTransformer predicts tissue-specific splicing linked to human diseases

Genomic features defining exonic variants that modulate splicing

Deep indel mutagenesis reveals the regulatory and modulatory architecture of alternative exon splicing

Co-expression Networks Uncover Regulation of Splicing and Transcription Markers of Disease.